Surveillance in Testicular Cancer: Who, When, What and How? - Abstract
Thursday, 15 November 2007
Department of Radiology, Royal Marsden Hospital, Sutton, Surrey, UK
read more
|
Primary Testicular Lymphoma - Abstract
Wednesday, 14 November 2007
Hematology Unit, Azienda Ospedaliera S. Giovanni Battista “Molinette”, Turin, Italy
read more
|
Testicular Cancer: Trends in Mortality are well Explained by Changes in Treatment and Survival in the Southern Netherlands Since 1970 - Abstract
Tuesday, 13 November 2007
Eindhoven Cancer Registry, Comprehensive Cancer Centre South (IKZ), P.O. Box 231, 5600 AE Eindhoven, The Netherlands
read more
|
Testicular Microlithiasis as a Familial Risk Factor for Testicular Germ Cell Tumour - Abstract
Monday, 12 November 2007
Testicular Cancer Genetics Team, Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK
read more
|
Rational Selection of Patients for Antibacterial Prophylaxis after Chemotherapy - Abstract
Wednesday, 07 November 2007
University Hospital Birmingham Cancer Centre, United Kingdom
read more
|
Cognitive Complaints and Cognitive Impairment Following BEP Chemotherapy in Patients with Testicular Cancer - Abstract
Monday, 05 November 2007
Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
read more
|
Characterization of a SEPT9 Interacting Protein, SEPT14, a Novel Testis-Specific Septin – Abstract
Thursday, 25 October 2007
Department of Human Genetics, The University of Michigan, Ann Arbor, Michigan, 48109, USA.
read more
|
Increased Risk of Testicular Cancer Among Infertile Men
Wednesday, 24 October 2007
WASHINGTON, DC (UroToday.com) - From the 63rd Annual Meeting of the American Society for Reproductive Medicine - October 13-17, 2007
read more
|
How Worrisome is Testicular Microlithiasis? – Abstract
Wednesday, 24 October 2007
University of Virginia Health System, Charlottesville, Virginia, USA.
read more
|
Expression of Fas and Fas ligand in Human Testicular Germ Cell Tumours – Abstract
Tuesday, 23 October 2007
Department of Experimental Medicine, ‘Sapienza’ University of Rome, Italy.
read more
|
Prenatal and Perinatal Risk Factors and Testicular Cancer: A Hospital-Based Case-Control Study – Abstract
Monday, 22 October 2007
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.
read more
|
Acute Anterior Myocardial Infarction after Chemotherapy for Testicular Seminoma in a Young Patient - Abstract
Friday, 19 October 2007
Department of Cardiology, Istanbul University, Istanbul, Turkey.
read more
|
Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer - Abstract
Thursday, 18 October 2007
Department of Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.
read more
|
The Role of Dead-End in Germ Cell Tumor Development - Abstract
Wednesday, 17 October 2007
Cancer Genetics, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas, 77030, United States.
read more
|
State-of-the-Art Surgical Management of Testicular Tumors - Abstract
Tuesday, 16 October 2007
Center for Robotic & Computer-Assisted Surgery, 410 W 10th Avenue, 538 Doan Hall, Columbus, Ohio 43210-1228, USA. keutl.shah@osumc.edu
read more
|
Beyond the Abstract - Extragonadal Retroperitoneal Germ Cell Tumor: Primary versus Metastases?
Thursday, 11 October 2007
BERKELEY, CA (UroToday.com) - Primary extragonadal germ cell tumors (EGCT) are rare and account a small percentage, 2% to 5%, of all germ cell tumors.
Login to read more...
|
Organ-Sparing Surgery does not Lead to Greater Antisperm Antibody Levels than Orchidectomy - Abstract
Thursday, 11 October 2007
Department of Urology, Medical University Innsbruck, Austria
read more
|
Beyond the Abstract - Incorporation of TIP (Paclitaxel, Ifosfamide, Cisplatin) into First-Line Therapy for Intermediate to Poor Risk Testicular Germ Cell Tumors with Unfavorable Marker Decline after Initial Two Cycles Chemotherapy: a Report of Three Cases
Wednesday, 10 October 2007
BERKELEY, CA (UroToday.com) - The most challenging part of the management of advanced testicular cancer is how to overcome refractory or absolutely refractory cases.
Login to read more...
|
Case Report: PET/CT, a Cautionary Tale - Abstract
Wednesday, 10 October 2007
Department of Medical Oncology, Imperial College School of Medicine, Charing Cross Hospital, London, UK.
read more
|
Environment, Testicular Dysgenesis and Carcinoma in Situ Testis - Abstract
Tuesday, 09 October 2007
University Department of Growth & Reproduction, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
read more
|
The Stem Cell Identity of Testicular Cancer - Abstract
Monday, 08 October 2007
Department of Molecular Cell and Developmental Biology, Institute for Stem Cell Biology and Medicine and the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 621 Charles E Young Drive South, Los Angeles, CA, 90054, USA
read more
|
Testicular Juvenile Granulosa Cell Tumor: a Case Report - Abstract
Friday, 05 October 2007
Anatomy and Pathology Service, São João Hospital, Porto, Portugal. hbarroca@gmail.com
read more
|
Extragonadal Retroperitoneal Germ Cell Tumor: Primary versus Metastases? - Abstract
Thursday, 04 October 2007
Department of Anatomic Pathology, Vargas Hospital, Caracas, Venezuela. parada@cantv.net
read more
|
Long-Term Complications of Platinum-Based Chemotherapy in Testicular Cancer Survivors - Abstract
Wednesday, 03 October 2007
Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, Unit 437, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA. jhoh@mdanderson.org
read more
|
Inhibitory Effects of a Nutrient Mixture on Human Testicular Cancer Cell Line NT 2/DT Matrigel Invasion and MMP Activity - Abstract
Tuesday, 02 October 2007
Cancer Division, Dr. Rath Research Institute, 1260 Memorex Drive, Santa Clara, CA, 95050, USA
read more
|
A Giant Testicular Teratoma - Abstract
Monday, 01 October 2007
Department of Surgery College of Medicine, Hawler Medical University, Erbil, Iraq. draqzangana@yahoo.com
read more
|
Current Management Strategies for Testicular Microlithiasis - Abstract
Friday, 28 September 2007
James Paget Hospital, Great Yarmouth, UK.
read more
|
Case Series: Adult Testicular Dermoid Tumours--Mature Teratoma or Pre-Pubertal Teratoma? - Abstract
Wednesday, 26 September 2007
Department of Cellular Pathology, Southampton University Hospitals NHS Trust, Tremona Road, SO16 6YD, Southampton, Hampshire, UK.
read more
|
Incorporation of TIP (Paclitaxel, Ifosfamide, Cisplatin) into First-Line Therapy for Intermediate to Poor Risk Testicular Germ Cell Tumors with Unfavorable Marker Decline after Initial Two Cycles Chemotherapy: a Report of Three Cases - Abstract
Tuesday, 25 September 2007
Komuro, Ina, Kita adachi gun, Saitama, Japan. ishioka@jb3.so-net.ne.jp
read more
|
Subfertility Among Parents of Men Diagnosed with Testicular Cancer - Abstract
Monday, 24 September 2007
Faculty of Health Sciences, Oslo University College, Oslo, Norway
read more
|
Testicular Cancer: Marked Birth Cohort Effects on Incidence and a Decline in Mortality in Southern Netherlands Since 1970 - Abstract
Wednesday, 19 September 2007
Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands.
read more
|
Comparative Mortality for 621 Second Cancers in 29356 Testicular Cancer Survivors and 12420 Matched First Cancers - Abstract
Friday, 07 September 2007
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. schairec@exchange.nih.gov
read more
|
Testicular Cancer Trends as 'Whistle Blowers' of Testicular Developmental Problems in Populations - Abstract
Thursday, 06 September 2007
University Department of Growth and Reproduction GR, Rigshospitalet, Copenhagen, Denmark. nes@rh.dk
read more
|
AUA 2007 - Recurrence in Patients with PNO at RPLND: Can We Predict Which Patients are at Risk
Friday, 25 May 2007
read more
|
AUA 2007 - Predicting Disease Progression in Patients with Viable Tumor at Post-Chemotherapy RPLND
Friday, 25 May 2007
read more
|
AUA 2007 Plenary Session: Presidential Address; “The Survival of Urology: Was Darwin Right?”
Thursday, 24 May 2007
read more
|
AUA 2007 - Sunday Plenary Session: The Expansion and Contraction of Urologic Practice
Sunday, 20 May 2007
read more
|
√ Age at Surgery for Undescended Testis and Risk of Testicular Cancer
Tuesday, 08 May 2007
√ Editor's Pick: BERKELEY, CA (UroToday.com) - While all urologists would agree that an undescended testis found in a school-age boy should be treated with an inguinal orchidopexy, whether the procedure results in a decrease in testicular cancer risk remains unclear.
read more
|
Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The NCRI Testis Cancer Clinical Studies Group
Friday, 27 April 2007
BERKELEY, CA (UroToday.com) - Select patients with stage I non-seminomatous germ cell tumors without lymphovascular invasion and with a low percentage of embryonal carcinoma are commonly followed expectantly due to their low incidence of recurrence.
read more
|
EAU 2007 - Debate - Plenary Session
Wednesday, 28 March 2007
read more
|
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
Wednesday, 14 March 2007
BERKELEY, CA (UroToday.com) - On March 9, 2007, the Food and Drug Administration issued a safety warning for all erythropoiesis-stimulating agents
read more
|
European Urology - TC Incidence Increasing: Spread the Word
Tuesday, 13 March 2007
read more
|
European Urology - Failure of High-Dose Cyclophosphamide and Etoposide Combined with Double-Dose Cisplatin and Bone Marrow Support in Patients with High-Volume Metastatic Nonseminomatous Germ-Cell Tumours: Mature Results of a Randomised Trial
Thursday, 01 March 2007
Volume 51, Issue 3, Pages 739-748 (March 2007)
Abstract -
Objectives:
To assess the impact on survival of high-dose chemotherapy with haematopoietic support in patients with high-volume, metastatic nonseminomatous germ cell tumours.
read more
|
Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma
Monday, 19 February 2007
BERKELEY, CA (UroToday.com) - Patient with residual masses after chemotherapy for mixed germ cell tumors should undergo retroperitoneal lymphadenectomy to address the measurable incidence of teratoma (40%) and viable cancer in the retroperitoneum.
read more
|
Poor-Prognosis Germ Cell Tumors: We Have Not Yet Crossed the Finish Line
Friday, 16 February 2007
BERKELEY, CA (UroToday.com) - Despite the dramatic impact of cisplatin-based chemotherapy on the treatment of testicular cancer as a whole, a small percentage of patients with high-risk tumors will fail first-line chemotherapy and carry a measurable cancer-specific mortality.
read more
|
European Urology - Testicular Cancer Variations in Time and Space in Europe
Tuesday, 13 February 2007
Volume 51, Issue 3, Pages 621-628 (March 2007)
1. Introduction
Testicular cancer (TC) is the most common cancer in young men aged 20–34 yr and represents about 1% of all tumours in men.
read more
|
European Urology - Residual Tumour Resection Following Inductive Chemotherapy in Advanced Testicular Cancer
Monday, 12 February 2007
Volume 51, Issue 2, Pages 299-301 (February 2007) Surgical resection of postchemotherapy residual retroperitoneal lymph nodes or residual visceral metastatic deposits represents an integral part of the multimodality treatment for patients with advanced testicular cancer undergoing inductive systemic chemotherapy [1].
read more
|
European Urology - Predicting Retroperitoneal Histology in Postchemotherapy Testicular Germ Cell Cancer: A Model Update and Multicentre Validation with More Than 1000 Patients
Monday, 12 February 2007
Volume 51, Issue 2, Pages 424-432 (February 2007) 1. Introduction: Cisplatin-based chemotherapy is highly effective as treatment of advanced nonseminomatous testicular germ cell cancer. Surgical resection after chemotherapy is a standard approach to remove enlarged (≥10mm) retroperitoneal lymph nodes.
read more
|
European Urology - Testicular Cancer Variations in Time and Space in Europe
Monday, 05 February 2007
Volume 51, Issue 3, Pages 621-628 (March 2007)
1. Introduction
Testicular cancer (TC) is the most common cancer in young men aged 20–34 yr and represents about 1% of all tumours in men.
read more
|
European Urology - Management of Stage I Testis Cancer
Monday, 15 January 2007
Volume 51, Issue 1, Pages 34-44 (January 2007)
Abstract -
Objective:
Over the last 5 years the management of stage I testis cancer has changed tremendously. This review focuses on the latest changes in diagnostics and treatment of clinical stage I non-seminomatous and seminomatous germ cell tumors.
read more
|
Testicular Cancer 
